biOasis Technologies Ord Shs BIOAF

$.02

[prophetoffactz]

Phase II ready EGF assets and xB3 applications.
Chiesi deal and BTI's own Lysosomal Storage pipeline(Hunter, Gaucher's).
Herceptin.
xB3-004.
xB3-009.
siRNA and gene-therapy.
Neuramedy.
J&J multi-product option.
Prothena.
Midatech.

[Boomskid]

I forgot. Bioasis is not at 1.5¢ today. Bioasis was up 33.3% today, from 1.5¢ to 2¢. Does Bioasis still have a deal with Prothena? My guess? Yes, but I doubt any work is being done. It will be 5 years this year since the Prothena deal was announced. Not too likely that Prothena is still in the pab with that, if it ever was. Why is xB3-001 still absent from the list, poof? Has

[fuzzyjr]

it's nice to see the many possibilities without dishing out personal attacks like some. Much more refreshing looking at the positives that are still possible, believe most here have had more than enough of the negativity related to anything possible or positive. I'm waiting on one or more of the many positive possibilities to hit us via an NR to re-enter this & watch it run for several